Please anonymize the following clinical note. Specifically, replace all the following information with the term “[redacted]”: redact any strings that might be a name or acronym or initial, redact any strings separated by the \/ symbol, redact patients' names, doctors' names and the strings in front of M.D. or after Dr., redact pager names and medical staff names, redact any strings that look like something years old or age 37, redact any dates and IDs and numbers and record dates, redact locations and addresses and clinic names, redact professions and ages and contacts, redact any acronyms and initials.: 



Record date: 2090-11-21


CC: recent hospitalization and f/up of DM and HTN management


HPI: 62 yo female who presents back to clinic after recent hospitalization 11/13-11/16 with
atypical chest pain.  She underwent evaluation with MR stress test which revealed inferior
ischemia.  Underwent cath and RCA stent placement.  Since then, pt reports some mild
SOB and CP only once shortly 1 day after discharge.  No headaches.
Denies any symptoms of hyperglycemia or hypoglycemia.



Problems
Menopause at age 52 
H/O R sided sciatica 
H/O pneumonia 1/2082 
S/P vocal cord cyst removal 
S/P cholecystectomy 
S/P C section x 2 
Diabetes mellitus type 2 : onset 2067
Severe nonproliferative diabetic retinopathy with severe macular edema 
H/O pyelonephritis 
1/16/88 cardiac MIBI with summed stress score of 0 but evidence of extensive calcified coronary plaque burden with coronary calcium score of 715 
Hypertension 
Depression 
7/23/88 R shoulder arthroscopy 
4/20/89 lumbar CT : No stenosis or disc herniation, mild deg changes of the lower lumbar spine as described with a possible tiny lateral disc protrusion on the L at L3-L4.

CAD s/p RCA stent placement 11/2090


Medications
Amitriptyline HCL 25 MG (25MG TABLET Take 1) PO QHS PRN neuropathic pain , for pain - para el dolor #30 Tablet(s)
Cozaar (LOSARTAN) 100MG TABLET Take 1 PO QD #30 Tablet(s)
Darvocet N 100 (PROPOXYPHENE NAP/ACETAMIN... 1 TAB PO BID PRN pain - dolor #60 Tablet(s)
Ecasa (ASPIRIN ENTERIC COATED) 325 MG (325MG TABLET Take 1) PO QD #30 Tablet(s)
Ergocalciferol 50000 UNITS (50000 UNIT CAPSULE Take 1) PO QWEEK #1 Month(s) Supply
Lantus (INSULIN GLARGINE) 88 UNITS SC QAM #1 Month(s) Supply
Lasix (FUROSEMIDE) 20 MG (20MG TABLET Take 1) PO QD #1 Month(s) Supply
Lipitor (ATORVASTATIN) 80 MG (80MG TABLET Take 1) PO QD #30 Tablet(s)
Lisinopril 5 MG (5MG TABLET Take 1) PO QD x 30 days #30 Tablet(s)
Neurontin (GABAPENTIN) 300 MG (300MG CAPSULE Take 1) PO BID #60 Tablet(s)
Niaspan (NICOTINIC ACID SUSTAINED RELEASE) 1000 MG (1000MG TABLET SA Take 1) PO QHS #90 Tablet(s)
Nifedipine (EXTENDED RELEASE) 60 MG (60MG TABLET Take 1) PO QPM x 30 days #30 Tablet(s)
Paxil (PAROXETINE) 20MG TABLET Take 1 Tablet(s) PO QD #30 Tablet(s)
Plavix (CLOPIDOGREL) 75 MG (75MG TABLET Take 1) PO QD #30 Tablet(s)
Prilosec (OMEPRAZOLE) 20 MG (20MG CAPSULE DR Take 1) PO QD , before eating #30 Capsule(s)
Toprol XL (METOPROLOL SUCCINATE EXTENDED RELEASE) 200 MG (200MG TAB.SR 24H Take 1) PO QD #30 TAB.SR




Allergies
NKA 


PEx: Vital Signs: BP 117/56, P 67, Wt 184.6 lbs
WDWN older female in NAD.  
HEENT: anicteric sclerae  
Neck: supple, no JVD.  
Lungs: CTA.  
CV: RRR, s1s2, nl, II/VI SEM at LSB
Abd: soft, NT  
Ext: no c/c/bil 1+ edema.  


A/P:
1. HTN/CHF.  BP improved with newer medical regimen since discharge,
scheduled for Cards f/up 12/91, now on Plavix.  Dietary and exercise rec's reviewed.
Counseling given regarding recent RCA stent placement.

2. DM, stable, recent A1C 9.1 on 11/14/90, increased Lantus to 88 units as directed 
and dietary rec's reviewed.  Following.
3. Scheduled for renal evaluation 12/14/90.


Singh, M.D.















































































































































































































































































-





-










































































































































-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-














N/A





















































































































-

-





-
-
-







-
-

































-


















-









-
-








-

-






























-

























































































date






\






\

or



































information





























name















1




words




words, information,

names.


and information names


Information, the words





information


words or words, and/words.

or 

names and name

let 
name and names or the patient names and name

patient and remove, and replace patient name, the names

or or identification

12, but, names

names or


or and the names... or..., and/1, or the words and
names.
and or... and... 1...


...
The...
name...

name and name (10 or the and, but and any or names of the names, names,...
the, 1, and the 12.

and names,
name... 80:
names 111, and:
name, 3:

1:...

are, the......17...: [… (
are: the name are are and the 

or 8 are 1 (the and, the…, and and:... 1 or the… and, and 

...
andize the and 12 or: (the (... and and ((
1... (…1…and (are  are the, 11: …. or 0...
1, or and are, 1...... or, a, and (including, 1 and, and,, 2, and (...1, the. or, (an, the... [are,  are, (are, 1, and the and, the and and are the, and, and,  of the and of a and ( and,, [any,...: and (1 (an:...1.
: “1… and “. 3 and…2. 3. 1 1 are are are... of an are, (in,..., by  by,,, and the, the, the and, (le, [[..., of the, [of the...,, or,, or, (le, (are, and (an are are- are the would are the... (an and by, ( (2 an, (1 or,  an, an,, and  of  (an and, 2 of the, an, an of a, an,  an an an an an,  an, an- 0, An Anist,, the  (and, and, and,,,, 1 and,,, and,,  and,,: the, "and and,, (1 (1, (1 ( an and, an and-1 of:  [0- an:: An: :: An:::  (:,::: ( and : "::: ::: an- and a a- an or: ( or or or of: or an of: : are- and- or an or- [- ( [ ( an " of  of the an an  or  in an,  or or (,, in [ an, [ [  ( ( and are [ are [ [ [, and or [- an... [:  are " are an an or- an of the an an, - - an an an an  an and [ an an  -, an or and,, of an of the of " or of and or of, and and the  and [ and, an  and an an,, of an of the of “ of " an of an " an  ( an an or- - or,,  or or  an- in for, or  an or, or or an, an, or [ ( for for or of the of  of " of the and of :  (: and and  or - and  and and in or or of the an- - in (  in (  and, -2 or,  an an  and or- c and, of, of  of " ( and ( and and or, and,, (, (, or and an,  and an- or of or or  of  or of   of the,  ( and - or or and  of an and of of an of of  of of of  of of C of and and and, and or [ c an  and of and and c ( and  an An An An 4 2 An-1 an or or ( c [ and  of  of an of ( or,  ( an  [  or  and or and or ( an c an [ or  and [ or an and or  or and and "  ( C An C  C and ( and or  for and  c in for or of of c of  and (1 m  C and " C C P R or: : and-  and  and c  or    2  1:  c and  ( - or:  C A  c of  or of  c  "   and or and- or    or  of  of  of  and of  of  - An and  (,  and  c or and C c  or   and  of  of   of of and  of, H1     H  H and and, H and and, and H-  and    or,  ( (,   and  (  and and -  and of  C C   of  C ( C A and:,  and or C C and   ( and   of   and or   1 or   2  C (   or  or an an  (    (,  C and [ and, c and C and and  C and (  and  and (1 ( and,, (,  and C, 0 H and ( , C  and  (  and and and,  H   and  H C and  and  ( C, and and, and C  ( P H C and and,  C, 2 ( C  C,,  [,,  (2 ( ( 1  of 1 0  1 H  and. (, C., H. H (, C (, and, [ H ( C H C and (  (, C C (,, [ C and or A H C and and  C T Cl C  C and  ( C and C C H and and T and  C, C ( H and and C  and  and and C and  and C [ C M H and [, C ( ( [ or  [1 (  C [1 C 1 and ( or and  (, H,, C and,, and and,, C C1 and and A of C, of,,, ( M, and ( C, and C C C (1 A1 CA of C of C and of  and of m of A  and, C C C,, C, and M, C C C  M  ( C  C, and C ( ( and and ( ( S1 C, A,  S C1 M ( C C Cl C of H and of A Cl (, of M, and and, C and and,